SCHEMBL15399710

SCHEMBL15399710

Nc1cc(-c2coc3cc(OS(N)(=O)=O)ccc3c2=O)ccc1OS(N)(=O)=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 2/20 0.69
MAPT P10636 7/20 0.55
RAB9A P51151 7/20 0.55
NPC1 O15118 6/20 0.55
KDM4E B2RXH2 4/20 0.47
POLB P06746 2/20 0.47
HMGB1 P09429 1/20 0.47
XDH P47989 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
TP53 P04637 3/20 0.46
MEN1 O00255 3/20 0.46
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 3/20 0.46
CYP3A4 P08684 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
ALDH2 P05091 6/20 0.46
MAOA P21397 4/20 0.46
MAOB P27338 4/20 0.46
HSD17B10 Q99714 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15398844 0.92 STS (0.65) STSMAPTRAB9ANPC1KDM4E
SCHEMBL17988714 0.90 STS (0.55) STSMAPTRAB9ANPC1KDM4E
SCHEMBL15399462 0.84 STS (0.63) STSMAPTRAB9ANPC1KDM4E
SCHEMBL17991998 0.83 MAPT (0.65) STSMAPTRAB9ANPC1KDM4E
SCHEMBL15398755 0.83 RAB9A (0.62) STSMAPTRAB9ANPC1KDM4E
SCHEMBL15399312 0.82 STS (0.73) STSMAPTRAB9ANPC1KDM4E
SCHEMBL17988704 0.77 STS (0.65) STSMAPTRAB9ANPC1KDM4E
SCHEMBL17988700 0.76 NPC1 (0.45) STSMAPTRAB9ANPC1KDM4E
SCHEMBL17988706 0.76 MIF (0.55) STSMAPTRAB9ANPC1KDM4E
SCHEMBL17988699 0.75 STS (0.49) STSMAPTRAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9409859-B2 Substituted diphenyl derivatives CREATIVE THERAPEUTICS GMBH (DE) 2016-08-09 US disclosed
US-20140005149-A1 Substituted diphenyl derivatives CREATIVE THERAPEUTICS GMBH (DE) 2014-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140005149-A1 Substituted diphenyl derivatives DPYD, VHL, TP53 STS 3633/4885MAPT 3367/4885RAB9A 3295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.